Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Ardelyx, Inc. ARDX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$17.00
+169.8%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Ardelyx, Inc. (ARDX), dont 18 achats et 27 ventes. Le total des achats d'initiés s'élève à $17.5M et le total des ventes d'initiés à $1.3M.

Les initiés notables ayant une activité récente comprennent Dinavahi Rajani, Raab Michael, Mott David M. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — ARDX

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-04-01 Dinavahi Rajani Chief Medical Officer Inconnu 301,000 $6.11 $1.84M -
2026-03-16 Raab Michael President & CEO Exercice d'Options (Vente) 20,833 $0.99 $20.62K 374,168
2026-02-24 Raab Michael President & CEO Exercice d'Options (Vente) 20,833 $0.99 $20.62K 395,001
2026-02-20 Mott David M Director Achat Informatif 333,333 $5.84 $1.95M 3,302,918
2026-02-20 Bishop John E See Remarks Vente Informative 1 $5.70 $5.70 339,151
2026-02-20 Raab Michael President & CEO Vente Informative 2 $5.70 $11.40 1,856,986
2026-02-20 Williams Laura A See Remarks Vente Informative 984 $5.71 $5.62K 436,082
2026-02-20 Kelliher Mike See Remarks Vente Informative 2 $5.71 $11.41 364,666
2026-02-20 Foster Eric Duane Chief Commercial Officer Vente Informative 1 $5.70 $5.70 425,970
2026-02-20 Reilly Joseph James See Remarks Vente Informative 2 $5.70 $11.40 151,790
2026-02-20 Brady James Parker Chief Human Resources Officer Vente Informative 309 $5.71 $1.77K 262,912
2026-02-20 Hohenleitner Susan Chief Financial Officer Vente Informative 247 $5.71 $1.41K 230,533
2026-01-23 Bishop John E See Remarks Attribution de RSU 186,500 $7.77 $1.45M 186,500
2026-01-23 Raab Michael President & CEO Attribution de RSU 669,330 $7.77 $5.2M 669,330
2026-01-23 Williams Laura A Chief Patient Officer Attribution de RSU 124,040 $7.77 $963.79K 124,040
2026-01-23 Kelliher Mike See Remarks Attribution de RSU 154,625 $7.77 $1.2M 154,625
2026-01-23 Foster Eric Duane Chief Commercial Officer Attribution de RSU 206,915 $7.77 $1.61M 206,915
2026-01-23 Brady James Parker Chief Human Resources Officer Attribution de RSU 149,185 $7.77 $1.16M 149,185
2026-01-23 Hohenleitner Susan Chief Financial Officer Attribution de RSU 128,505 $7.77 $998.48K 128,505
2026-01-23 Reilly Joseph James See Remarks Attribution de RSU 69,360 $7.77 $538.93K 69,360
2026-01-08 Williams Laura A Chief Patient Officer Exercice d'Options (Vente) - $0.99 - 62,000
2025-11-21 Grammer Elizabeth A See Remarks Vente Informative 5,995 $5.54 $33.19K 299,895
2025-11-21 Raab Michael President & CEO Vente Informative 46,887 $5.54 $259.61K 1,455,363
2025-11-21 Williams Laura A Chief Patient Officer Vente Informative 6,426 $5.54 $35.58K 359,896
2025-11-21 Kelliher Mike See Remarks Vente Informative 5,560 $5.54 $30.79K 271,181
2025-11-21 Foster Eric Duane Chief Commercial Officer Vente Informative 5,814 $5.54 $32.19K 295,684
2025-11-21 Reilly Joseph James See Remarks Vente Informative 11,086 $5.54 $61.38K 108,914
2025-11-04 Hohenleitner Susan Chief Financial Officer Inconnu 578,104 $5.01 $2.9M -
2025-08-26 Williams Laura A Chief Patient Officer Exercice d'Options (Vente) 50,000 $0.99 $49.5K 112,000
2025-08-21 Grammer Elizabeth A See Remarks Vente Informative 5,841 $5.93 $34.65K 305,890
2025-08-21 Raab Michael President & CEO Vente Informative 45,687 $5.93 $271K 1,502,250
2025-08-21 Renz Justin A Chief Financial Officer Vente Informative 7,037 $5.93 $41.74K 409,052
2025-08-21 Williams Laura A Chief Patient Officer Vente Informative 6,261 $5.93 $37.14K 396,322
2025-08-21 Foster Eric Duane Chief Commercial Officer Vente Informative 15,308 $5.93 $90.8K 301,498
2025-08-21 Kelliher Mike Chief Business Officer Vente Informative 5,417 $5.93 $32.13K 276,741
2025-08-01 Bishop John E See Remarks Inconnu 327,000 $4.49 $1.47M -
2025-08-01 Conner Edward R. Chief Medical Officer Inconnu 463,268 $5.21 $2.41M -
2025-06-18 Brady James Parker Chief Human Resources Officer Inconnu 250,000 $3.93 $982.5K -
2025-06-18 Mott David M Director Attribution de RSU 54,059 $3.61 $195.15K 54,059
2025-06-18 Bertrand William C Jr Director Attribution de RSU 54,059 $3.61 $195.15K 54,059
2025-06-18 Rodgers Richard J Director Attribution de RSU 54,059 $3.61 $195.15K 54,059
2025-06-18 Bazemore Robert B Director Attribution de RSU 41,551 - - 41,551
2025-06-18 Parsey Merdad Director Attribution de RSU 15,235 - - 57,291
2025-06-18 Cadoret-manier Onaiza Director Attribution de RSU 54,059 $3.61 $195.15K 54,059
2025-06-18 Bhanji Muna Director Attribution de RSU 54,059 $3.61 $195.15K 54,059
2025-06-16 Mott David M Director Achat Informatif 200,000 $3.63 $725.88K 2,896,871
2025-06-09 Mott David M Director Achat Informatif 200,000 $3.69 $737.26K 2,696,871
2025-05-20 Grammer Elizabeth A See Remarks Vente Informative 5,992 $4.08 $24.46K 311,731
2025-05-20 Raab Michael President & CEO Vente Informative 46,817 $4.08 $191.08K 1,547,937
2025-05-20 Renz Justin A Chief Financial Officer Vente Informative 7,218 $4.08 $29.46K 416,089
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message